Bempedoic acid may prevent dangerous blood clots from forming in addition to reducing risk for major cardiovascular events vs. placebo in statin-intolerant people with prior CVD or at high risk for it, researchers reported.Bempedoic acid (Nexletol, Esperion Therapeutics) significantly reduced risk for venous thromboembolism, including both deep vein thrombosis and pulmonary embolism, compared